Retraction: UM-164: A Potent c-Src/p38 Kinase Inhibitor with In Vivo Activity against Triple-Negative Breast Cancer. Gilani RA, Phadke S, Bao LW, Lachacz EJ, et al. Clin Cancer Res 2020;26:1777.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gilani RA, Phadke S, Bao LW, Lachacz EJ, et al. Retraction: UM-164: A Potent c-Src/p38 Kinase Inhibitor with In Vivo Activity against Triple-Negative Breast Cancer. Clin Cancer Res 2020;26:1777.
PMID: 32238414